Heart-type fatty acid-binding protein is a useful marker for organ dysfunction and leptin alleviates sepsis-induced organ injuries by restraining its tissue levels

European Journal of Pharmacology

Volumn 616, Issue 1-3, 2009, Pages 244-250

  Yan, Guang tao ^a   Lin, Ji ^a   Hao, Xiu hua ^a   Xue, Hui ^a   Zhang, Kai ^a   Wang, Lu huan ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Heart type fatty acid binding protein; Leptin; Multiple organ dysfunction syndrome; Radioimmunoassay; Recovery of function; Sepsis

Indexed keywords

ALANINE AMINOTRANSFERASE; C REACTIVE PROTEIN; FATTY ACID BINDING PROTEIN; HEART TYPE FATTY ACID BINDING PROTEIN; INTERLEUKIN 1BETA; LEPTIN; MYELOPEROXIDASE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; URIC ACID;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HISTOPATHOLOGY; HUMAN; INTESTINE; LUNG INFECTION; LUNG PARENCHYMA; MAJOR CLINICAL STUDY; MALE; MOUSE; MULTIPLE ORGAN FAILURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN TARGETING; RABBIT; RADIOIMMUNOASSAY; SEPSIS; TISSUE LEVEL; URIC ACID BLOOD LEVEL;

ADULT; ALANINE TRANSAMINASE; ANIMALS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; FATTY ACID-BINDING PROTEINS; FEMALE; HUMANS; INTERLEUKIN-1BETA; LEPTIN; MALE; MICE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; PEROXIDASE; RABBITS; RADIOIMMUNOASSAY; REPRODUCIBILITY OF RESULTS; SEPSIS; SUPEROXIDE DISMUTASE; URIC ACID;

EID: 67651114122     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2009.06.039     Document Type: Article

References (31)

1. Augustin A.J., and Lutz J. Intestinal, hepatic and renal production of thiobarbituric acid reactive substances and myeloperoxidase activity after temporary aortic occlusion and reperfusion. Life Sci. 49 (1991) 961-968
2. Bone R.C., Balk R.A., Cerra F.B., Dellinger R.P., Fein A.M., Knaus W.A., Schein R.M., and Sibbald W.J. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 101 (1992) 1644-1655
3. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
4. Caldefie-Chezet F., Poulin A., and Vasson M.P. Leptin regulates functional capacities of polymorphonuclear neutrophils. Free Radic. Res. 37 (2003) 809-814
5. Canbakan B., Tahan V., Balci H., Hatemi I., Erer B., Ozbay G., Sut N., Hacibekiroglu M., Imeryuz N., and Senturk H. Leptin in nonalcoholic fatty liver disease. Ann. Hepatol. 7 (2008) 249-254
6. Ceddia R.B. Direct metabolic regulation in skeletal muscle and fat tissue by leptin: implications for glucose and fatty acids homeostasis. Int. J. Obes. (Lond) 29 (2005) 1175-1183
7. Chmurzynska A. The multigene family of fatty acid-binding proteins (FABPs): function, structure and polymorphism. J. Appl. Genet. 47 (2006) 39-48
8. Crawford J.H., Yang S., Zhou M., Simms H.H., and Wang P. Down-regulation of hepatic CYP1A2 plays an important role in inflammatory responses in sepsis. Crit. Care Med. 32 (2004) 502-508
9. Edelson M.B., Sonnino R.E., Bagwell C.E., Lieberman J.M., Marks W.H., and Rozycki H.J. Plasma intestinal fatty acid binding protein in neonates with necrotizing enterocolitis: a pilot study. J. Pediatr. Surg. 34 (1999) 1453-1457
10. Erol E., Kumar L.S., Cline G.W., Shulman G.I., Kelly D.P., and Binas B. Liver fatty acid binding protein is required for high rates of hepatic fatty acid oxidation but not for the action of PPARalpha in fasting mice. FASEB J. 18 (2004) 347-349
11. Fruhbeck G. Intracellular signalling pathways activated by leptin. Biochem. J. 393 (2006) 7-20
12. Gaigé S., Abou E., Abysique A., and Bouvier M. Effects of interactions between interleukin-1 beta and leptin on cat intestinal vagal mechanoreceptors. J. Physiol. 555 (2004) 297-310
13. Johnson D., and Mayers I. Multiple organ dysfunction syndrome: a narrative review. Can. J. Anaesth. 48 (2001) 502-509
14. Lin J., Yan G.T., Hao X.H., Wang L.H., Zhang K., and Xue H. Effect of intestinal ischemia-reperfusion injury on protein levels of leptin and orexin-A in peripheral blood and central secretory tissues. World J. Gastroenterol. 11 (2005) 1000-1004
15. Mad P., Domanovits H., Fazelnia C., Stiassny K., Russmüller G., Cseh A., Sodeck G., Binder T., Christ G., Szekeres T., Laggner A., and Herkner H. Human heart-type fatty-acid-binding protein as a point-of-care test in the early diagnosis of acute myocardial infarction. QJM. 100 (2007) 203-210
16. Malle E., Steinmetz A., and Raynes J.G. Serum amyloid A (SAA): an acute phase protein and apolipoprotein. Atherosclerosis 102 (1993) 131-146
17. Marshall J.C., Cook D.J., Christou N.V., Bernard G.R., Sprung C.L., and Sibbald W.J. Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit. Care Med. 23 (1995) 1638-1652
18. Maruna P., Gürlich R., Frasko R., and Haluzík M. Serum leptin levels in septic men correlate well with C-reactive protein (CRP) and TNF-alpha but not with BMI. Physiol. Res. 50 (2001) 589-594
19. McConnico R.S., Weinstock D., Poston M.E., and Roberts M.C. Myeloperoxidase activity of the large intestine in an equine model of acute colitis. Am. J. Vet. Res. 60 (1999) 807-813
20. McCord J.M., and Fridovich I. Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J. Biol. Chem. 244 (1969) 6049-6055
21. Naveau S., Perlemuter G., Chaillet M., Raynard B., Balian A., Beuzen F., Portier A., Galanaud P., Emilie D., and Chaput J.C. Serum leptin in patients with alcoholic liver disease. Alcohol. Clin. Exp. Res. 30 (2006) 1422-1428
22. Ono T. Studies of the FABP family: a retrospective. Mol. Cell. Biochem. 277 (2005) 1-6
23. Palacio A., Lopez M., Perez-Bravo F., Monkeberg F., and Schlesinger L. Leptin levels are associated with immune response in malnourished infants. J. Clin. Endocrinol. Metab. 87 (2002) 3040-3046
24. Pinteaux E., Inoue W., Schmidt L., Molina-Holgado F., Rothwell N.J., and Luheshi G.N. Leptin induces interleukin-1beta release from rat microglial cells through a caspase 1 independent mechanism. J. Neurochem. 102 (2007) 826-833
25. Remick D.G., Bolgos G.R., Siddiqui J., Shin J., and Nemzek J.A. Six at six: interleukin-6 measured 6 h after the initiation of sepsis predicts mortality over 3 days. Shock 17 (2002) 463-467
26. Suganami T., Mukoyama M., Mori K., Yokoi H., Koshikawa M., Sawai K., Hidaka S., Ebihara K., Tanaka T., Sugawara A., Kawachi H., Vinson C., Ogawa Y., and Nakao K. Prevention and reversal of renal injury by leptin in a new mouse model of diabetic nephropathy. FASEB J. 19 (2005) 127-129
27. Todd M.K., Yaspelkis III B.B., and Turcotte L.P. Short-term leptin treatment increases fatty acids uptake and oxidation in muscle of high fat-fed rats. Metabolism. 54 (2005) 1218-1224
28. Veerkamp J.H., and Maatman R.G. Cytoplasmic fatty acid-binding proteins: their structure and genes. Prog. Lipid Res. 34 (1995) 17-52
29. Wang Q., Li H., Liu S., Wang G., and Wang Y. Cloning and tissue expression of chicken heart fatty acid-binding protein and intestine fatty acid-binding protein genes. Anim. Biotechnol. 16 (2005) 191-201
30. Watanabe T., Ohkubo Y., Matsuoka H., Kimura H., Sakai Y., Ohkaru Y., Tanaka T., and Kitaura Y. Development of a simple whole blood panel test for detection of human heart-type fatty acid-binding protein. Clin. Biochem. 34 (2001) 257-263
31. William Jr. W.N., Ceddia R.B., and Curi R. Leptin controls the fate of fatty acids in isolated rat white adipocytes. J. Endocrinol. 175 (2002) 735-744